Wed. 7 Feb 2024, 8:35am ET
Benzinga
News, Management
Dr. Boger is the founder, and retired CEO and Board Chair, of Vertex Pharmaceuticals
CervoMed on track to complete enrollment in 1H 2024 in its RewinD-LB Phase 2b clinical trial evaluating neflamapimod in patients with dementia with Lewy bodies; topline data expected in 2H 2024